VCYT FY2025 SEC EDGAR DEF 14A #29 of 31 in industry

Veracyte, Inc. CEO pay ratio

The CEO earned $7.5M in FY2025 against median worker pay of $196,646 · Health Services.

Health Services peers All rankings
State
DE
Filing date
2026-04-22
Industry
Health Services
Industry rank
#29/31

Data updated August 2026

Subscribe to Veracyte, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
38:1
Below Average (Scale: 0–1000:1)
CEO pay
$7.5M
Median worker
$196,646

Answer first

Veracyte, Inc.'s FY2025 CEO total of $7.5M ranks #733 of 1,423 complete filings; its 38:1 pay ratio ranks #1071. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $196,646. Industry placement uses the FY2025 SIC-80 peer cohort (# 29 of 31, 10th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Health Services companies.

Dollar rank
#733
$7.5M of 1,423 FY2025
Ratio rank
#1071
38:1 of 1,423
Industry pct
10th
among the lower quartile of industry peers by pay ratio

How Veracyte, Inc. ranks nationally

Veracyte, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$7,472,548 48th percentile higher than 48% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). This entry sits in this band. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Veracyte, Inc. vs. Health Services peers

CEO total pay ($7.5M) against pay ratio (38:1) for Veracyte, Inc. (marked) and its 5 closest same-industry peers, against the Health Services industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02688509.45377018.88065528.210754037.633.5:158.5:183.5:1108.5:1133.6:1CEO total payPay ratio (CEO : median worker)Veracyte, Inc., CEO total pay: 7472548 · Pay ratio (CEO : median worker): 38:1Veracyte, Inc.Guardant Health, Inc., CEO total pay: 8730392 · Pay ratio (CEO : median worker): 44:1Guardant Health, Inc.Progyny, Inc., CEO total pay: 7220612 · Pay ratio (CEO : median worker): 46:1Progyny, Inc.CareDx, Inc., CEO total pay: 148417 · Pay ratio (CEO : median worker): 48:1CareDx, Inc.Community Health Systems Inc, CEO total pay: 4772869 · Pay ratio (CEO : median worker): 60:1Community Health Systems IncViemed Healthcare, Inc., CEO total pay: 2636836 · Pay ratio (CEO : median worker): 68:1Viemed Healthcare, Inc.
Veracyte, Inc. vs. Health Services peers, plotted against the industry's $10.2M median CEO total and 129:1 median pay ratio.

Ratio bands among Health Services peers

Exclusive CEO-to-median-worker bands across 29 complete latest-FY filings in SIC 80. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Veracyte, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Veracyte, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
38:1
FY2025
vs prior FY
-6:1
from FY2024 44:1
CEO $ YoY
+9.7%
$7.5M latest
Filings shown
4
FY2022–2025
Veracyte, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $4.9M - $129,449 38:1 -
2023 $7.2M +46% $143,268 50:1 +12:1
2024 $6.8M -4.9% $154,756 44:1 -6:1
2025 $7.5M +9.7% $196,646 38:1 -6:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1384101, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Health Services

This Company's Ratio
38:1
Industry Median Ratio
129:1
Industry Median CEO Pay
$10.2M
This CEO's Pay
$7.5M
Companies in Industry
31
vs. Industry Median
Below
#29 of 31 by pay ratio in this industry View all companies in Health Services →

Veracyte, Inc.: MODEST · HEAVY pay ratio

Veracyte, Inc.'s FY2025 ratio 38:1 ranks #29 of 31 Health Services filers (10th percentile). the CEO earned 38× the median employee ($196,646) in FY2025.

Median employee $196,646 (ELITE-MED); MODEST · HEAVY stamps put about 38 median-wage years per CEO year.

CEO Total Pay

$7.5M

FY2025 Summary Compensation, below median

Pay Ratio

38:1

Below typical

Veracyte, Inc. in the lower Health Services third

Veracyte, Inc.'s FY2025 ratio 38:1 ranks #29 of 31 Health Services filers (10th percentile). The structured pay-ratio disclosure reports the total without line-item components. Health Services (SIC 80) median ratio is 129:1 across 31 FY2025 filers; Veracyte, Inc.'s $7.5M CEO total is at or below the $10.2M industry median CEO pay.

Dollar rank #733 and ratio rank #1071 split - treat 38:1 as a disclosure, not a fairness score. Open Health Services peers.

Key Data, FY2025

Total Compensation
$7.5M
Median Employee Pay
$196,646
Pay Ratio
38:1
Filing Date
2026-04-22

Company Info

Ticker
VCYT
CIK
1384101
Industry
Health Services
SIC Code
8071
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1384101, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Veracyte, Inc.'s FY2025 ratio 38:1 ranks #29 of 31 Health Services filers (10th percentile).

Read with Veracyte, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Enpro Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.5M (Δ $6K heavier vs Veracyte, Inc.); MID · PAR-MED vs this page's MODEST · HEAVY · ELITE-MED.
Trinity Industries Inc · HEAVY

ABS(ceo_total_comp) peer at $7.5M (Δ $8K lighter vs Veracyte, Inc.); STEEP · LOW-MED vs this page's MODEST · HEAVY · ELITE-MED.
Brixmor Property Group Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.5M (Δ $16K heavier vs Veracyte, Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Bath & Body Works, Inc. · HEAVY

ABS(ceo_total_comp) peer at $7.5M (Δ $20K heavier vs Veracyte, Inc.); EXTREME · LOW-MED vs this page's MODEST · HEAVY · ELITE-MED.
Guardant Health, Inc. (SIC 80 pole)

Guardant Health, Inc. stamps MODEST · HEAVY nearest in-SIC by ABS(pay_ratio) to Veracyte, Inc.'s MODEST filing.
National dual ranks · #733/#1071

Veracyte, Inc.'s FY2025 package sits #733 by CEO dollars and #1071 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Veracyte, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Veracyte, Inc. (CIK 1384101), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.